Plus Therapeutics, Inc.
PSTV
$0.7691
-$0.075-8.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.98M | -12.89M | -13.23M | -11.77M | -13.32M |
| Total Depreciation and Amortization | 723.00K | 685.00K | 641.00K | 625.00K | 628.00K |
| Total Amortization of Deferred Charges | 20.00K | 50.00K | 91.00K | 140.00K | 190.00K |
| Total Other Non-Cash Items | -1.54M | -1.50M | -394.00K | 770.00K | 763.00K |
| Change in Net Operating Assets | 3.22M | 2.43M | 2.95M | -1.33M | -1.12M |
| Cash from Operations | -10.55M | -11.22M | -9.94M | -11.57M | -12.85M |
| Capital Expenditure | -146.00K | -177.00K | -173.00K | -103.00K | -160.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.97M | -4.04M | -4.05M | -324.00K | -- |
| Cash from Investing | -4.11M | -4.22M | -4.22M | -427.00K | -160.00K |
| Total Debt Issued | 3.29M | 3.29M | 3.29M | -- | -- |
| Total Debt Repaid | -4.00M | -4.40M | -4.80M | -1.61M | -1.61M |
| Issuance of Common Stock | 7.27M | 7.41M | 10.53M | 4.63M | 5.53M |
| Repurchase of Common Stock | -374.00K | -500.00K | -500.00K | -500.00K | -126.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -148.00K | -348.00K | -348.00K | -348.00K |
| Cash from Financing | 6.19M | 5.66M | 8.18M | 2.18M | 3.45M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.48M | -9.78M | -5.98M | -9.82M | -9.57M |